Supernus Pharm (SUPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SUPN | TEVA | BBIO | RDY | BHC |
| Company | Supernus Pharm | Teva Pharmaceutical Industries ADR | Bridgebio Pharma Inc | Dr. Reddy's Laboratories Ltd ADR | Bausch Health Companies Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NYSE |
| Open | 52.21 | 31.99 | 76.77 | 14.08 | 7.32 |
| High | 52.30 | 31.99 | 77.32 | 14.12 | 7.34 |
| Low | 51.01 | 31.50 | 76.38 | 14.03 | 7.15 |
| Latest | 51.77 | 31.74 | 76.53 | 14.09 | 7.18 |
| Change | +0.06 | +0.20 | +0.13 | -0.14 | -0.14 |
| % Change | +0.12% | +0.63% | +0.17% | -0.98% | -1.91% |
| Volume | 209,000 | 3,794,200 | 548,500 | 365,700 | 979,700 |
| 20-Day Average Volume | 673,535 | 10,403,295 | 1,829,030 | 1,137,060 | 2,883,320 |
| Previous Close | 51.71 | 31.54 | 76.40 | 14.23 | 7.32 |
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 47.44 | 29.18 | 74.10 | 14.04 | 6.91 |
| 20-Day Raw Stochastic | 93.54% | 96.00% | 77.10% | 66.18% | 73.76% |
| 20-Day Relative Strength | 63.86 | 82.07 | 65.63 | 51.49 | 57.57 |
| Weighted Alpha | +51.25 | +79.87 | +186.12 | -8.07 | -18.13 |
| Today's Opinion | 88% Buy | 100% Buy | 100% Buy | 40% Sell | 88% Buy |
| Previous Opinion | 88% Buy | 100% Buy | 100% Buy | 8% Sell | 88% Buy |
| Last Month's Opinion | 40% Buy | 100% Buy | 100% Buy | 72% Sell | 16% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.19% since 12/17/25 | +5.59% since 12/17/25 | +3.39% since 12/17/25 | +1.15% since 12/17/25 | +5.28% since 12/17/25 |
| Low | 47.98 on 12/19/25 | 29.88 on 12/18/25 | 73.48 on 12/18/25 | 13.93 on 12/18/25 | 6.74 on 12/22/25 |
| High | 52.30 on 12/24/25 | 31.99 on 12/24/25 | 78.44 on 12/22/25 | 14.32 on 12/23/25 | 7.35 on 12/23/25 |
| 1-Month | |||||
| %Chg | +14.66% since 11/24/25 | +28.14% since 11/24/25 | +7.80% since 11/24/25 | +3.15% since 11/24/25 | +17.51% since 11/24/25 |
| Low | 44.09 on 12/02/25 | 24.78 on 11/25/25 | 69.53 on 11/25/25 | 13.64 on 12/08/25 | 6.13 on 11/25/25 |
| High | 52.30 on 12/24/25 | 31.99 on 12/24/25 | 78.44 on 12/22/25 | 14.32 on 12/23/25 | 7.55 on 12/04/25 |
| 3-Month | |||||
| %Chg | +9.92% since 09/24/25 | +64.71% since 09/24/25 | +51.10% since 09/24/25 | -2.42% since 09/24/25 | +7.97% since 09/24/25 |
| Low | 43.11 on 11/05/25 | 18.21 on 09/25/25 | 48.78 on 09/25/25 | 13.14 on 10/29/25 | 5.88 on 10/29/25 |
| High | 57.65 on 10/30/25 | 31.99 on 12/24/25 | 78.44 on 12/22/25 | 14.95 on 10/22/25 | 7.55 on 12/04/25 |
| 6-Month | |||||
| %Chg | +63.47% since 06/24/25 | +85.72% since 06/24/25 | +72.17% since 06/24/25 | -9.62% since 06/24/25 | +15.81% since 06/24/25 |
| Low | 30.83 on 06/25/25 | 14.99 on 08/01/25 | 41.80 on 07/01/25 | 13.14 on 10/29/25 | 5.50 on 07/31/25 |
| High | 57.65 on 10/30/25 | 31.99 on 12/24/25 | 78.44 on 12/22/25 | 15.71 on 06/25/25 | 8.69 on 08/15/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,968,440 | 36,404,512 | 14,748,019 | 11,764,276 | 2,662,746 |
| Shares Outstanding, K | 57,339 | 1,146,960 | 192,709 | 834,938 | 370,856 |
| Annual Sales | 661,820,000 | 16,544,000,000 | 221,900,000 | 3,811,000,000 | 9,625,000,000 |
| Annual Net Income | 73,870,000 | -1,639,000,000 | -535,760,000 | 663,000,000 | -46,000,000 |
| Last Quarter Sales | 192,100,000 | 4,480,000,000 | 120,700,000 | 1,012,590,000 | 2,681,000,000 |
| Last Quarter Net Income | -45,120,000 | 433,000,000 | -182,740,000 | 165,280,000 | 179,000,000 |
| 60-Month Beta | 0.71 | 0.67 | 1.26 | 0.39 | 0.41 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.01 on 11/04/25 | 0.78 on 11/05/25 | -0.95 on 10/29/25 | 0.19 on 10/24/25 | 1.16 on 10/29/25 |
| Latest Earnings Date | 02/24/26 | 01/28/26 | 02/19/26 | 01/22/26 | 02/18/26 |
| Most Recent Dividend | N/A | 0.072 on 11/27/17 | N/A | 0.071 on 07/25/25 | 1.000 on 11/10/10 |
| Next Ex-Dividends Date | N/A | 11/27/17 | N/A | 07/25/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 24.28 | 12.22 | 0.00 | 17.57 | 1.93 |